Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  cladribine
Find trials that include:  Any drugs shown
Results 1-11 of 11 for your search:
Start Over
Cladribine, Cytarabine, and Filgrastim in Combination with Selinexor in Treating Patients with Relapsed or Refractory Acute Myeloid Leukemia
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 to 70
Trial IDs: 201505084, NCI-2015-00828, NCT02416908
Filgrastim, Cladribine, Cytarabine and Mitoxantrone with or without Sorafenib Tosylate in Treating Patients with Newly-Diagnosed, High-Risk Acute Myeloid Leukemia or Myelodysplastic Syndrome
Status: Not yet active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 60
Trial IDs: 9510, NCI-2016-00286, NCT02728050
Cladribine and Rituximab in Treating Patients with Hairy Cell Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2004-0223, NCI-2012-01394, NCT00412594
Cladribine with Simultaneous or Delayed Rituximab in Treating Patients with Hairy Cell Leukemia
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 09-C-0005, NCI-2013-01595, NCT00781235, P08372, NCT00923013
Cladribine, Cytarabine, and Decitabine in Treating Patients with Untreated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Status: Active
Phase: Phase II
Type: Treatment
Age: 60 and over
Trial IDs: 2011-0987, NCI-2012-00145, NCT01515527
DNA Methyltransferase Inhibitor SGI-110 with or without Idarubicin or Cladribine in Treating Older Patients with Previously Untreated Acute Myeloid Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: Over 70
Trial IDs: 2013-0843, NCI-2014-00981, NCT02096055
Sequential Busulfan, Cladribine, and Fludarabine Phosphate before Donor Stem Cell Transplant in Treating Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndromes
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 2 to 70
Trial IDs: 2014-0431, NCI-2014-02324, NCT02250937
Decitabine, Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients with Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Status: Not yet active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 9713, NCI-2016-01401, NCT02921061
Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients with Relapsed or Refractory Acute Myeloid Leukemia
Status: Not yet active
Phase: No phase specified
Type: Treatment
Age: 18 to 75
Trial IDs: 9567, NCI-2016-00477, NCT02756572
Start Over